Details of the Drug
General Information of Drug (ID: DM2W0AD)
| Drug Name |
5-p-Tolyl-1H-[1,2,3]triazole
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
4-(p-Tolyl)-1H-1,2,3-triazole; 5301-96-2; 4-(p-Tolyl)-2H-1,2,3-triazole; 5-(4-methylphenyl)-1H-1,2,3-triazole; 1H-1,2,3-Triazole, 4-(4-methylphenyl)-; 4-(4-methylphenyl)-2H-triazole; 5-(p-Tolyl)-1H-1,2,3-triazole; 59066-81-8; v-Triazole, 4-p-tolyl-; AC1LC4W8; SCHEMBL20848; 1,2,3-triazole analogue, 3; CHEMBL193610; CTK1G1560; BDBM17447; DTXSID60344093; ZPCIKQLLQORQCV-UHFFFAOYSA-N; MolPort-023-332-536; 4-p-tolyl-1H-1,2,3-triazole; ZINC13671868; ANW-65599; AKOS015907809; FCH4165656; KS-0000101Z; SC-23256; AJ-64294; AK-90097
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 159.19 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.6 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


